Further, the number of CD11c+ cells in the tumor tissue was independent of cancer type (Fig 9B and 9F), although the number of infiltrating cells was elevated in later stages of lung cancer [47 (40...56) stage III vs. 11(4...28) stage I lung cancer, Fig 9C]. This evidence concerns the gene ITGAX and cancer.